Resusc Plus. 2021 Mar 02;6:100095. doi: 10.1016/j.resplu.2021.100095. eCollection 2021 Jun.
Time boundaries of the three-phase time-sensitive model for ventricular fibrillation cardiac arrest.
Resuscitation plus
Yoshikazu Goto, Akira Funada, Tetsuo Maeda, Yumiko Goto
Affiliations
Affiliations
- Department of Emergency and Critical Care Medicine, Kanazawa University Hospital, Takaramachi 13-1, Kanazawa 920-8640, Japan.
- Department of Cardiology, Osaka Saiseikai Senri Hospital, Tsukumodai 1-1-6, Suita 565-0862, Japan.
- Department of Cardiology, Yawata Medical Center, Yawata I 12-7, Komatsu 923-8551, Japan.
PMID: 34223360
PMCID: PMC8244403 DOI: 10.1016/j.resplu.2021.100095
Abstract
AIM: Ventricular fibrillation (VF) cardiac arrest may consist of three time-sensitive phases: electrical, circulatory, and metabolic. However, the time boundaries of these phases are unclear. We aimed to determine the time boundaries of the three-phase model for VF cardiac arrest.
METHODS: We reviewed 20,741 out-of-hospital cardiac arrest cases with initial VF and presumed cardiac origin from the All-Japan Utstein-style registry between 2013 and 2017. The study endpoint was 1-month neurologically intact survival. The collapse-to-shock interval was defined as the time from collapse to the first shock delivery by emergency medical service personnel. The patients were divided into the bystander cardiopulmonary resuscitation (CPR,
RESULTS: In the bystander CPR group, the collapse-to-shock times that were associated with increased adjusted 1-month neurologically intact survival, compared with those in the non-bystander CPR group, ranged from 7 min (42.9% [244/4999] vs. 26.0% [119/458], adjusted odds ratio [aOR], 1.95; 95% confidence interval [CI], 1.44-2.63;
CONCLUSIONS: The time boundaries of the three-phase time-sensitive model for VF cardiac arrest may be defined as follows: electrical phase, from collapse to <7 min; circulatory phase, from 7 to 17 min; and metabolic phase, from >17 min onward.
© 2021 The Authors.
Keywords: Cardiac arrest; Cardiopulmonary resuscitation; Epidemiology; Outcomes; Ventricular fibrillation
References
- JAMA. 2002 Dec 18;288(23):3035-8 - PubMed
- Circulation. 2000 Aug 22;102(8 Suppl):I60-76 - PubMed
- J Am Coll Cardiol. 2014 Sep 30;64(13):1362-9 - PubMed
- Circulation. 2015 Sep 29;132(13):1286-300 - PubMed
- Am J Cardiol. 2006 Aug 15;98(4):497-9 - PubMed
- Resuscitation. 2018 Dec;133:82-87 - PubMed
- Resuscitation. 2019 Feb;135:191-196 - PubMed
- JAMA. 2018 Apr 10;319(14):1429-1430 - PubMed
- Circulation. 2015 Feb 3;131(5):478-87 - PubMed
- J Thorac Dis. 2019 Sep;11(9):3853-3863 - PubMed
- Circulation. 2015 Oct 20;132(16 Suppl 1):S2-39 - PubMed
- Resuscitation. 2008 Dec;79(3):424-31 - PubMed
- Am J Emerg Med. 2014 Jun;32(6):586-91 - PubMed
- JAMA. 1992 Oct 28;268(16):2184-98 - PubMed
- Circulation. 2004 Nov 23;110(21):3385-97 - PubMed
- Lancet. 2020 Dec 21;394(10216):2255-2262 - PubMed
- N Engl J Med. 2016 Oct 27;375(17):1649-1659 - PubMed
- Resuscitation. 2005 Mar;64(3):341-6 - PubMed
- Resuscitation. 2007 May;73(2):229-35 - PubMed
- Nat Hum Behav. 2018 Jan;2(1):6-10 - PubMed
Publication Types